Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000260

Chief Executive Officer acquired 921 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kummeth Charles R. · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-11 Exercise or conversion : show line 1 in the form +921 $108.49 $99,919 165,114 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-11 Exercise or conversion : show line 2 in the form Stock Options (Right to Buy) −921 173,942 D
Loading xslF345X03/edgar.xml…